Entero's weak listing follows a lukewarm response to its Rs 1,600-crore IPO. The maiden share sale had garnered just 1.5 times subscription
Yatharth Hospital added that the bed capacity will be expanded to 200 to 220 beds post acquisition
Max Healthcare Institute on Friday said it has acquired Nagpur-based Alexis Multi-Speciality Hospital Pvt Ltd for Rs 412 crore. The 200-bed hospital is set up on a land parcel of 2-acre at Mankapur, north of Nagpur. The facility has potential to increase its bed capacity from 200 operational beds to 340 beds after necessary regulatory approvals. "The acquisition of Alexis Hospital is in line with our vision to expand our footprint in tier-2 cities with abundance of clinical talent and developed private healthcare infrastructure," Max Healthcare Institute Chairman and Managing Director Abhay Soi said. Alexis Hospital acquisition will strengthen company's presence in Maharashtra region, he added. Shares of Max Healthcare were trading at a loss of 0.42 per cent at Rs 866.4 apiece on the BSE.
Healthcare products distributor Entero Healthcare Solutions has collected Rs 716 crore from anchor investors. The company has allotted a total of 56.95 lakh equity shares to 25 funds at Rs 1,258 a piece, which is also the upper end of the price band, according to a circular uploaded on BSE's website late on Thursday. The anchor book saw participation from investors, including the Capital Group, Government of Singapore, Monetary Authority of Singapore, Amundi Funds New Silk Road, Societe Generale, Morgan Stanley Asia (Singapore) Pte, Goldman Sachs (Singapore) Pte, and Copthall Mauritius Investment Ltd. Additionally, Bajaj Allianz Life Insurance Company, SBI General Insurance, and Jupiter India Fund participated in the anchor round. The issue, with a price band of Rs 1,195-1,258 per share, opened for public subscription on Friday. It will close on February 13. The Rs 1,600 crore IPO is a combination of a fresh issue of equity shares worth up to Rs 1,000 crore and an Offer For Sale (
In FY23, Entero Healthcare reported Rs 33,00.20 crore in revenue from operations with a gross profit of Rs 268.34 crore
With this strategic acquisition, Thyrocare will expand its footprint in the pre-policy medical check-up segment for the insurance market
On a sequential basis, the company exhibited a 5.63 per cent decline in revenue along with PAT, which declined by 23.41 per cent
The October-December quarter encompasses the tail end of the monsoon as well as winter, which brings with them ailments such as influenza and stomach flu
Revenue and margins to remain healthy next financial year, too
For the Indian business in Q3 FY24, the revenue stood at Rs 1,180 crore Y-o-Y with a growth of 5 per cent and a sequential decline of 1 per cent
Demand will be for data scientists, developers and cybersecurity specialists, it says
Neelesh Surana expresses concerns over the quality of rally in certain smallcap pockets
Interim budget 2024: Here's what the experts of the real estate sector expect from the Centre
Currently, only 63 per cent of customers avail cashless treatment, whereas the remaining 47 per cent opt for reimbursement claims
Nearly 48 per cent of healthcare and pharma companies surveyed are poised to integrate first-gen AI solutions within one year, an EY report said on Wednesday. The shift is, however, significant in the sector, which has been traditionally conservative in adopting digital technologies, it added. The findings also underline the growing appeal of this emerging technology that has made headlines with its promise of transforming industries. The EY report insights revealed that in healthcare, Gen AI holds the promise of benefiting every facet of the value chain, from clinical services to customer operations and branding. Similarly, in life sciences, the potential of Gen AI applications is poised to expedite the assimilation of cutting-edge technologies across the value chain. According to the report, 60 per cent of survey participants from the healthcare and life sciences sector believe Gen AI will have a significant impact on the entire value chain. "While 28 per cent of healthcare and
Hospital chain Aster DM Healthcare on Tuesday said its shareholders have approved the proposal to hive off its Gulf business in a deal valued at USD 1.01 billion. The proposed resolutions were passed with the requisite majority by shareholders on January 22, the company said in a regulatory filing. Over 99 per cent of the votes polled were in favour of the deal, it added. On November 28 last year, Aster DM Healthcare announced that it would separate its India and Gulf businesses by way of a deal worth over USD 1 billion. The company stated that it has received approval from its board and subsidiary Affinity Holdings Pvt Ltd to separate the India and GCC businesses into two distinct and standalone entities. Under the separation plan, Affinity entered into a definitive agreement with a consortium of investors led by Fajr Capital, a private equity firm headquartered in the UAE, to invest in Aster's GCC business. Upon completion, the separation of the India and GCC businesses will ..
The initial public offering (IPO) of Nova Agritech garnered nearly 10 times subscription on Tuesday, the opening day of the issue. Most of the bids on the first day came from individual investors
In the healthcare segment, hospitals are expected to post revenue growth of 13 percent during the coverage, while the net profit growth would be around 37 percent, ICICI Securities said in a note
Established a century ago, the AMM Hospital, known locally as the 'oru ruba' (one rupee, which is the fee charged from patients) hospital, has been a beacon of quality healthcare for local community
Medi Assist covers over 18,000 hospitals across 1,069 cities and 31 states and has 35 insurers as partners